Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
Pattara Rattanawong, Win K. Shen, Hicham El Masry, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 14
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Arrhythmias and COVID-19
Parinita Dherange, Joshua Lang, Pierre Qian, et al.
JACC. Clinical electrophysiology (2020) Vol. 6, Iss. 9, pp. 1193-1204
Open Access | Times Cited: 150
COVID-19 infection and cardiac arrhythmias
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis, et al.
Trends in Cardiovascular Medicine (2020) Vol. 30, Iss. 8, pp. 451-460
Open Access | Times Cited: 125
Management of Arrhythmias Associated with COVID-19
Amar D. Desai, Brian C. Boursiquot, Lea Melki, et al.
Current Cardiology Reports (2020) Vol. 23, Iss. 1
Open Access | Times Cited: 72
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study
Sara París, Riccardo M. Inciardi, Carlo Lombardi, et al.
EP Europace (2021) Vol. 23, Iss. 10, pp. 1603-1611
Open Access | Times Cited: 46
Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
Stephanie L. Harrison, Elnara Fazio‐Eynullayeva, Deirdre A. Lane, et al.
Journal of Arrhythmia (2020) Vol. 37, Iss. 1, pp. 231-237
Open Access | Times Cited: 40
Arrhythmias in the COVID-19 patient
Michael P. Lavelle, Amar D. Desai, Elaine Y. Wan
Heart Rhythm O2 (2022) Vol. 3, Iss. 1, pp. 8-14
Open Access | Times Cited: 28
Physiologically‐Based Pharmacokinetic Modeling‐Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID‐19 Treatment
Ziteng Wang, Eric Chun Yong Chan
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 4, pp. 803-807
Open Access | Times Cited: 23
COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research
Sri Harsha Kanuri, Prapthi Jayesh Sirrkay, Ayse Sena Ulucay
The Egyptian Heart Journal (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 11
Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing
Md. Ariful Islam, Md. Kaderi Kibria, Md. Bayazid Hossen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections
Bandhan Sarker, Md. Matiur Rahaman, Md. Ariful Islam, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281981-e0281981
Open Access | Times Cited: 7
Cardiac Arrhythmias in Critically Ill Patients With COVID-19: A Brief Review
Kunal Karamchandani, Ashley Quintili, Terra Landis, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2020) Vol. 35, Iss. 12, pp. 3789-3796
Open Access | Times Cited: 20
Incidence, Mortality, and Imaging Outcomes of Atrial Arrhythmias in COVID-19
Qasim Jehangir, Yi Lee, Katie Latack, et al.
The American Journal of Cardiology (2022) Vol. 173, pp. 64-72
Open Access | Times Cited: 12
Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL* protocol
Teodoro Iturbe-Hernández, Luis García de Guadiana‐Romualdo, I. Ortega, et al.
Drugs in Context (2020) Vol. 9, pp. 1-12
Open Access | Times Cited: 16
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
Alberto Palazzuoli, Matteo Beltrami, Peter A. McCullough
Biomedicines (2023) Vol. 11, Iss. 3, pp. 790-790
Open Access | Times Cited: 5
New-onset atrial fibrillation among COVID-19 patients: A narrative review
Fahimeh Talaei, Akshat Banga, Amanda Pursell, et al.
World Journal of Critical Care Medicine (2023) Vol. 12, Iss. 5, pp. 236-247
Open Access | Times Cited: 5
Pharmacotherapy of atrial fibrillation in COVID-19 patients
Anna Tomaszuk‐Kazberuk, Marek Koziński, Justyna Domienik‐Karłowicz, et al.
Cardiology Journal (2021) Vol. 28, Iss. 5, pp. 758-766
Open Access | Times Cited: 12
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data
Lanting Yang, Shangbin Tang, Meiqi He, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Influence of the COVID-19 pandemic on patients receiving oral anticoagulants for the treatment of non-valvular atrial fibrillation
Josep Comín‐Colet, Antoni Sicras‐Mainar, Joel Salazar‐Mendiguchía, et al.
IJC Heart & Vasculature (2024) Vol. 51, pp. 101358-101358
Open Access | Times Cited: 1
Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
Athanasios Kartalis, Dimitrios Afendoulis, Petros Voutas, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 2, pp. 334-341
Open Access | Times Cited: 1
The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis
Sebastian Schnaubelt, Hans Domanovits, Jan Niederdoeckl, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 10
Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019
Nicole Lao, Joseph Lim, Hanad Bashir, et al.
Journal of Cardiology (2021) Vol. 79, Iss. 4, pp. 482-488
Open Access | Times Cited: 9
Medium-Term Outcomes in COVID-19
Zaki Akhtar, Sumeet Sharma, Ahmed I. Elbatran, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 2033-2033
Open Access | Times Cited: 5
Emerging therapeutics for the management of COVID 19
Sujit Kumar Debnath, Rohit Srivastava, Abdelwahab Omri
Expert Opinion on Emerging Drugs (2020) Vol. 25, Iss. 3, pp. 337-351
Closed Access | Times Cited: 7
Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19
Steven Deitelzweig, Julia Zhu, Jenny Jiang, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 11, pp. 1891-1896
Closed Access | Times Cited: 4
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study
Carlos Escobar, Ramón Bover Freire, Xavier García–Moll, et al.
Cardiovascular Diagnosis and Therapy (2023) Vol. 13, Iss. 5, pp. 777-791
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top